Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Balko

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|March 17, 2022
Mechanisms of MHC-I Downregulation and Role in Immunotherapy ResponseBrandie C Taylor, Justin M Balko
BMC Cancer|May 15, 2009
A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancerJustin M Balko, Esther P Black
Discovery Medicine|June 3, 2014
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancerJennifer M Giltnane, Justin M Balko
Cancer Biology & Therapy|November 26, 2008
Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signatureJustin M Balko, Esther P Black
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?Douglas B Johnson, Justin M Balko
Molecular & Cellular Oncology|September 22, 2016
Maybe we don't know JAK?Luis J Schwarz, Justin M Balko
Cell Stress|June 22, 2019
Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancerNa Luo, Ayaka Sugiura, Justin M Balko
Expert Review of Molecular Diagnostics|February 14, 2025
Peripheral blood biomarkers in monitoring treatment response in breast cancer patientsAndres A Ocampo, Xiaopeng Sun, Justin M Balko
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTodd W Miller, Justin M Balko, Carlos L Arteaga
Breast Cancer Research : BCR|August 3, 2013
The genomic map of breast cancer: which roads lead to better targeted therapies?Justin M Balko, Thomas P Stricker, Carlos L Arteaga
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|March 17, 2022
Mechanisms of MHC-I Downregulation and Role in Immunotherapy ResponseBrandie C Taylor, Justin M Balko
BMC Cancer|May 15, 2009
A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancerJustin M Balko, Esther P Black
Discovery Medicine|June 3, 2014
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancerJennifer M Giltnane, Justin M Balko
Cancer Biology & Therapy|November 26, 2008
Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signatureJustin M Balko, Esther P Black
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?Douglas B Johnson, Justin M Balko
Molecular & Cellular Oncology|September 22, 2016
Maybe we don't know JAK?Luis J Schwarz, Justin M Balko
Cell Stress|June 22, 2019
Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancerNa Luo, Ayaka Sugiura, Justin M Balko
Expert Review of Molecular Diagnostics|February 14, 2025
Peripheral blood biomarkers in monitoring treatment response in breast cancer patientsAndres A Ocampo, Xiaopeng Sun, Justin M Balko
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTodd W Miller, Justin M Balko, Carlos L Arteaga
Breast Cancer Research : BCR|August 3, 2013
The genomic map of breast cancer: which roads lead to better targeted therapies?Justin M Balko, Thomas P Stricker, Carlos L Arteaga
Pageof 18